A randomized pilot study of dietary treatments for polycystic ovary syndrome in adolescents

Pediatric Obesity

Volumn 11, Issue 3, 2016, Pages 210-220

  Wong, J M W ^a,b   Gallagher, M ^a   Gooding, H ^a   Feldman, H A ^a   Gordon, C M ^c   Ludwig, D S ^a   Ebbeling, C B ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c HASBRO CHILDREN'S HOSPITAL   (United States)

Author keywords

Bioavailable testosterone; dietary intervention; electronic medical record; polycystic ovary syndrome

Indexed keywords

CONTRACEPTIVE AGENT; TESTOSTERONE;

ADOLESCENT; ADOLESCENT OBESITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET THERAPY; DIETARY COMPLIANCE; DIETARY REFERENCE INTAKE; FEMALE; GLYCEMIC LOAD; HUMAN; HYPERANDROGENISM; LOW FAT DIET; LOW GLYCEMIC LOAD; NUTRITION EDUCATION; NUTRITIONAL COUNSELING; OUTCOME ASSESSMENT; OVARY POLYCYSTIC DISEASE; PATIENT SATISFACTION; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TELECONSULTATION; TESTOSTERONE BLOOD LEVEL; WEIGHT CONTROL; ADULT; BODY COMPOSITION; COMPLICATION; COOKING; COUNSELING; DIET; INSULIN RESISTANCE; OBESITY; PATIENT EDUCATION; PROCEDURES;

ADOLESCENT; ADULT; BODY COMPOSITION; COOKING; COUNSELING; DIET; DIET, FAT-RESTRICTED; FEMALE; GLYCEMIC LOAD; HUMANS; INSULIN RESISTANCE; OBESITY; OVERWEIGHT; PATIENT EDUCATION AS TOPIC; PILOT PROJECTS; POLYCYSTIC OVARY SYNDROME;

EID: 84934779645     PISSN: 20476302     EISSN: 20476310     Source Type: Journal    
DOI: 10.1111/ijpo.12047     Document Type: Article

References (29)

1. Azziz R, Carmina E, Dewailly D, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 2009; 91: 456-488.
2. Franks S,. Adult polycystic ovary syndrome begins in childhood. Best Pract Res Clin Endocrinol Metab 2002; 16: 263-272.
3. Fruzzetti F, Perini D, Lazzarini V, Parrini D, Genazzani AR,. Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels. Fertil Steril 2009; 92: 626-634.
4. Lewy VD, Danadian K, Witchel SF, Arslanian S,. Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome. J Pediatr 2001; 138: 38-44.
5. Palmert MR, Gordon CM, Kartashov AI, Legro RS, Emans SJ, Dunaif A,. Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome. J Clin Endocrinol Metab 2002; 87: 1017-1023.
6. Coviello AD, Legro RS, Dunaif A,. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J Clin Endocrinol Metab 2006; 91: 492-497.
7. Steinberger J, Daniels SR, American Heart Association Atherosclerosis H, Obesity in the Young C, American Heart Association Diabetes C. Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism). Circulation 2003; 107: 1448-1453.
8. Silfen ME, Denburg MR, Manibo AM, et al. Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents. J Clin Endocrinol Metab 2003; 88: 4682-4688.
9. Glueck CJ, Morrison JA, Friedman LA, Goldenberg N, Stroop DM, Wang P,. Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents. Metabolism 2006; 55: 508-514.
10. Trent M, Austin SB, Rich M, Gordon CM,. Overweight status of adolescent girls with polycystic ovary syndrome: body mass index as mediator of quality of life. Ambul Pediatr 2005; 5: 107-111.
11. Moran LJ, Pasquali R, Teede HJ, Hoeger KM, Norman RJ,. Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society. Fertil Steril 2009; 92: 1966-1982.
12. Legro RS, Arslanian SA, Ehrmann DA, et al. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2013; 98: 4565-4592.
13. Azziz R, Carmina E, Dewailly D, et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 2006; 91: 4237-4245.
14. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, et al. CDC growth charts: United States. Adv Data 2000; (314): 1-27.
15. Rosal MC, Ebbeling CB, Lofgren I, Ockene JK, Ockene IS, Hebert JR,. Facilitating dietary change: the patient-centered counseling model. J Am Diet Assoc 2001; 101: 332-341.
16. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG,. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42: 377-381.
17. Hoeger K, Davidson K, Kochman L, Cherry T, Kopin L, Guzick DS,. The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials. J Clin Endocrinol Metab 2008; 93: 4299-4306.
18. Bridger T, MacDonald S, Baltzer F, Rodd C,. Randomized placebo-controlled trial of metformin for adolescents with polycystic ovary syndrome. Arch Pediatr Adolesc Med 2006; 160: 241-246.
19. Ornstein RM, Copperman NM, Jacobson MS,. Effect of weight loss on menstrual function in adolescents with polycystic ovary syndrome. J Pediatr Adolesc Gynecol 2011; 24: 161-165.
20. Sacks FM, Bray GA, Carey VJ, et al. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med 2009; 360: 859-873.
21. Mensink RP, Zock PL, Kester AD, Katan MB,. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 2003; 77: 1146-1155.
22. Roe AH, Dokras A,. The diagnosis of polycystic ovary syndrome in adolescents. Rev Obstet Gynecol 2011; 4: 45-51.
23. Pasquali R, Gambineri A, Cavazza C, et al. Heterogeneity in the responsiveness to long-term lifestyle intervention and predictability in obese women with polycystic ovary syndrome. Eur J Endocrinol 2011; 164: 53-60.
24. Gower BA, Chandler-Laney PC, Ovalle F, et al. Favourable metabolic effects of a eucaloric lower-carbohydrate diet in women with PCOS. Clin Endocrinol (Oxf) 2013; 79: 550-557.
25. Lass N, Kleber M, Winkel K, Wunsch R, Reinehr T,. Effect of lifestyle intervention on features of polycystic ovarian syndrome, metabolic syndrome, and intima-media thickness in obese adolescent girls. J Clin Endocrinol Metab 2011; 96: 3533-3540.
26. Moran LJ, Noakes M, Clifton PM, Tomlinson L, Galletly C, Norman RJ,. Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003; 88: 812-819.
27. Moran LJ, Noakes M, Clifton PM, Wittert GA, Williams G, Norman RJ,. Short-term meal replacements followed by dietary macronutrient restriction enhance weight loss in polycystic ovary syndrome. Am J Clin Nutr 2006; 84: 77-87.
28. Douglas CC, Gower BA, Darnell BE, Ovalle F, Oster RA, Azziz R,. Role of diet in the treatment of polycystic ovary syndrome. Fertil Steril 2006; 85: 679-688.
29. Marsh KA, Steinbeck KS, Atkinson FS, Petocz P, Brand-Miller JC,. Effect of a low glycemic index compared with a conventional healthy diet on polycystic ovary syndrome. Am J Clin Nutr 2010; 92: 83-92.